191 related articles for article (PubMed ID: 37291634)
1. High preoperative CEA and systemic inflammation response index (C-SIRI) predict unfavorable survival of resectable colorectal cancer.
Cai H; Chen Y; Zhang Q; Liu Y; Jia H
World J Surg Oncol; 2023 Jun; 21(1):178. PubMed ID: 37291634
[TBL] [Abstract][Full Text] [Related]
2. Preoperative inflammation and nutrition-based comprehensive biomarker for predicting prognosis in resectable colorectal cancer.
Cai H; Li J; Chen Y; Zhang Q; Liu Y; Jia H
Front Oncol; 2023; 13():1279487. PubMed ID: 38074640
[TBL] [Abstract][Full Text] [Related]
3. High Preoperative Fibrinogen and Systemic Inflammation Response Index (F-SIRI) Predict Unfavorable Survival of Resectable Gastric Cancer Patients.
Gao W; Zhang F; Ma T; Hao J
J Gastric Cancer; 2020 Jun; 20(2):202-211. PubMed ID: 32596003
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
5. Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer.
Ming-Sheng F; Mei-Ling D; Xun-Quan C; Yuan-Xin H; Wei-Jie Z; Qin-Cong P
Can J Gastroenterol Hepatol; 2022; 2022():3109165. PubMed ID: 35028301
[TBL] [Abstract][Full Text] [Related]
6. In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator.
Chen L; Chen Y; Zhang L; Xue Y; Zhang S; Li X; Song H
Pathol Oncol Res; 2021; 27():1609811. PubMed ID: 34712105
[No Abstract] [Full Text] [Related]
7. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
8. Predictive effect of the systemic inflammation response index (SIRI) on the efficacy and prognosis of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Ding Y; Liu Z; Li J; Niu W; Li C; Yu B
BMC Surg; 2024 Mar; 24(1):89. PubMed ID: 38481180
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy.
Zheng C; Ye S; Liu W; Diao M; Li L
Front Oncol; 2023; 13():1276175. PubMed ID: 37901310
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Inflammatory and Nutritional Markers for Patients With Early-Stage Poorly-to Moderately-Differentiated Cervical Squamous Cell Carcinoma.
Guo J; Lv W; Wang Z; Shang Y; Yang F; Zhang X; Xiao K; Zhang S; Pan X; Han Y; Zong L; Hu W
Cancer Control; 2023; 30():10732748221148913. PubMed ID: 36599103
[TBL] [Abstract][Full Text] [Related]
11. The systemic inflammation response index predicts survival and recurrence in patients with resectable pancreatic ductal adenocarcinoma.
Li S; Xu H; Wang W; Gao H; Li H; Zhang S; Xu J; Zhang W; Xu S; Li T; Ni Q; Yu X; Wu C; Liu L
Cancer Manag Res; 2019; 11():3327-3337. PubMed ID: 31114368
[No Abstract] [Full Text] [Related]
12. The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II-III Colorectal Cancer Patients After Curable Resection.
Ying HQ; Liao YC; Sun F; Peng HX; Cheng XX
J Inflamm Res; 2021; 14():115-129. PubMed ID: 33500648
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of the Systemic Inflammation Response Index in Patients with Adenocarcinoma of the Oesophagogastric Junction: A Propensity Score-Matched Analysis.
Chen Y; Jin M; Shao Y; Xu G
Dis Markers; 2019; 2019():4659048. PubMed ID: 31781301
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer].
Huang L; Fang J; Wu J; Zhou X; Wei H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1421-1426. PubMed ID: 30588596
[TBL] [Abstract][Full Text] [Related]
15. The preoperative systemic inflammation response index (SIRI) independently predicts survival in postmenopausal women with breast cancer.
Hua X; Long ZQ; Huang X; Deng JP; Wen W; He ZY; Guo L; Zhang WW; Lin HX
Curr Probl Cancer; 2020 Aug; 44(4):100560. PubMed ID: 32122667
[TBL] [Abstract][Full Text] [Related]
16. The systemic inflammation response index predicts the survival of patients with clinical T1-2N0 oral squamous cell carcinoma.
Song F; Cai H; Liao Y; Huang S; Jiang Y; Liang J; Xie N; Hou J
Oral Dis; 2022 Apr; 28(3):600-610. PubMed ID: 33486833
[TBL] [Abstract][Full Text] [Related]
17. The Pretreatment Systemic Inflammation Response Index as a Useful Prognostic Factor is Better Than Lymphocyte to Monocyte Ratio in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Jiang C; Zhang S; Qiao K; Xiu Y; Yu X; Huang Y
Clin Breast Cancer; 2022 Jul; 22(5):424-438. PubMed ID: 35428593
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the systemic inflammation response index in patients with aneurismal subarachnoid hemorrhage and a Nomogram model construction.
Zhang P; Li Y; Zhang H; Wang X; Dong L; Yan Z; She L; Wang X; Wei M; Tang C
Br J Neurosurg; 2023 Dec; 37(6):1560-1566. PubMed ID: 33044089
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study.
Hu M; Xu Q; Yang S; Han S; Zhu Y; Lin Q; Sun X; Liu H; Xu Y
Ann Transl Med; 2020 Oct; 8(20):1310. PubMed ID: 33209890
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
Cancer Manag Res; 2020; 12():1543-1567. PubMed ID: 32184659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
